ACHILLION PHARMACEUTICALS, INC...

NASDAQ: ACHN
$6.76
+$0.00 (+0.0%)
Closing price January 28, 2020
Pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk to a great amount of risk...
Its stock has suffered, but it is possible that Achillion’s interim trial results may have put the company back on the right track.
Tuesday’s top analyst upgrades, downgrades and initiations include Amgen, Dow Chemical, Fitbit, Office Depot, SanDisk, Wells Fargo and Yum! Brands.
Wednesday's top analyst upgrades, downgrades and initiations include Achillion Pharmaceuticals, Computer Sciences, Keurig Green Mountain, Sarepta Therapeutics and Splunk.
Cowen sees the potential for super-mergers in biotech, as well as a large group of smaller targets that may be in the sights of bigger companies now.
Wednesday's top analyst upgrades, downgrades and initiations includes Alcoa, Apache, Bob Evans, F5, Hain and McDonald's.
Source: Thinkstock24/7 Wall St. has tracked several stocks with key moves in the after-hours trading session on Tuesday. Some of these might not merit a full blown review on their own, but active...
Achillion Pharmaceuticals has announced updated interim results from an ongoing Phase 2 study and the stock saw a solid boost in Monday's trading.
Tuesday's top analyst upgrades, downgrades and initiations seen from Wall Street research calls include Baker Hughes, CryoLife, Halliburton, Nabors Industries, Red Hat and Sonus Networks.
A new research report from the analysts at UBS focuses on four companies that stand to benefit from rising demand for the drugs they produce that treat hepatitis C.
Market volatility jumped this past week to the highest level in almost two months and insiders were selling, taking some money off the table.
A new research report from UBS focuses on four top companies that are making great strides in treatments for patients -- and generating gigantic revenues.
These are the top analyst upgrades and downgrades from 24/7 Wall St. for Monday, August 18, 2015. They include Achillion Pharmaceuticals, GE, Monster Beverage, Newmont Mining and SeaWorld.
Source: ThinkstockStocks had a crazy end to the week on reports of tension escalation and fighting in Ukraine and Russia. Still, investors are looking to use market weakness to find bargain stocks....
Source: Jon OggStocks were firm yet again on Friday morning ahead of the PPI wholesale inflation report. Investors have been trying to decide where to put their money after the recent stock market...